喘-COPD重叠治疗的进展:对治疗方法的全面审查
Monisha Jayaprakash Sagayaraj1, Surabhi Panneerselvam2, Hemalatha Rengasamy Jeganathan3
1Department of Pharmaceutics, School of Pharmaceutical Sciences, Vels Institute of Science, Technology & Advanced Studies, Pallavaram, Chennai, Tamil Nadu, 600117, India.
像类固醇节约药物调节剂 (SGRMs) 和生物制剂这样的新疗法可以改善喘-COPD重叠 (ACO) 的管理. 个性化治疗策略是优化治疗结果和减少ACO患者副作用的关键.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 喘-COPD重叠 (ACO) 呈现出复杂的呼吸系统症状,增加疾病严重程度和高医疗利用率.
- 混合的呼吸道炎症和高度的炎症反应是ACO的特征,复杂化了传统的治疗方法.
- 传统的吸入性皮质类固醇 (ICS) 被使用,但具有显著的副作用,特别是在COPD患者中,推动了对新疗法的需求.
研究的目的:
- 审查ACO管理的现有和新型治疗干预措施,重点是皮质类固醇治疗.
- 探索传统ICS和新型类固醇节约药物调节剂 (SGRMs) 在ACO治疗中的作用.
- 突出个性化医学的进步,以优化患者的治疗结果,并最大限度地减少ACO的不良影响.
主要方法:
- 对既有和新兴类固醇药物的机制,疗效和副作用的批判性评估.
- 评估生物药物,特别是单克隆抗体,以向特定的炎症途径,如ACO中的eosinophilic炎症.
- 基于临床试验和最近的研究,对创新的吸入器设备和药物输送系统进行审查,以提高治疗的准确性和有效性.
主要成果:
- ICS对于ACO控制至关重要,但需要根据炎症模式对患者进行特定的定制.
- SGRMs显示出有效向炎症的潜力,并减少了副作用.
- 生物疗法对乙酸性炎症有希望,先进的输送系统提高了患者的服从性和结果.
结论:
- ACO管理需要量身定制的治疗计划,新的药物如SGRMs和生物药物提供了增强的治疗前景.
- 使用生物标志物和先进诊断的个性化医疗对于完善ACO治疗策略至关重要.
- 未来的研究应该集中在个性化方法上,以改善患者的生活质量并减少医疗保健系统的负担.
更多相关视频
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
